Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001493152-24-031378

CFO and Interim CEO bought 14,400 shares at $1.01 ($14,544)

From the SEC's structured data for this filing

Trades in this filing

Mack Gene · CFO and Interim CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-08-09 Purchase : show line 1 in the form +14,400 $1.01 $14,544 14,400 D
Open-market purchases · 14,400 sh · avg $1.01 · $14,544
Loading xslF345X05/ownership.xml…